These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 6508636

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia.
    Brunzell JD, Albers JJ, Chait A, Grundy SM, Groszek E, McDonald GB.
    J Lipid Res; 1983 Feb; 24(2):147-55. PubMed ID: 6403642
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia.
    Escolà-Gil JC, Julve J, Marzal-Casacuberta A, Ordóñez-Llanos J, González-Sastre F, Blanco-Vaca F.
    J Lipid Res; 2000 Aug; 41(8):1328-38. PubMed ID: 10946021
    [Abstract] [Full Text] [Related]

  • 10. Metabolism of apolipoproteins C-II, C-III, and B in hypertriglyceridemic men. Changes after heparin-induced lipolysis.
    Huff MW, Breckenridge WC, Strong WL, Wolfe BM.
    Arteriosclerosis; 1988 Aug; 8(5):471-9. PubMed ID: 3190554
    [Abstract] [Full Text] [Related]

  • 11. Effects of fish oil concentrate on lipoproteins and apolipoproteins in familial combined hyperlipidemia.
    Tatò F, Keller C, Wolfram G.
    Clin Investig; 1993 Apr; 71(4):314-8. PubMed ID: 8471818
    [Abstract] [Full Text] [Related]

  • 12. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
    Cummings MH, Watts GF, Umpleby M, Hennessy TR, Quiney JR, Sönksen PH.
    Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
    [Abstract] [Full Text] [Related]

  • 13. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN, Le NA, Goldberg IJ, Gibson JC, Rubinstein A, Wang-Iverson P, Norum R, Brown WV.
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [Abstract] [Full Text] [Related]

  • 14. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
    Zambon A, Brown BG, Deeb SS, Brunzell JD.
    J Intern Med; 2006 May; 259(5):473-80. PubMed ID: 16629853
    [Abstract] [Full Text] [Related]

  • 15. Bimodality of plasma apolipoprotein B levels in familial combined hyperlipidemia.
    Austin MA, Horowitz H, Wijsman E, Krauss RM, Brunzell J.
    Atherosclerosis; 1992 Jan; 92(1):67-77. PubMed ID: 1575822
    [Abstract] [Full Text] [Related]

  • 16. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability.
    Bredie SJ, de Bruin TW, Demacker PN, Kastelein JJ, Stalenhoef AF.
    Am J Cardiol; 1995 Feb 15; 75(5):348-53. PubMed ID: 7856526
    [Abstract] [Full Text] [Related]

  • 17. Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia.
    Venkatesan S, Cullen P, Pacy P, Halliday D, Scott J.
    Arterioscler Thromb; 1993 Jul 15; 13(7):1110-8. PubMed ID: 8318511
    [Abstract] [Full Text] [Related]

  • 18. Determinants of VLDL composition and apo B-containing particles in familial combined hyperlipidemia.
    Cruz-Bautista I, Mehta R, Cabiedes J, García-Ulloa C, Guillen-Pineda LE, Almeda-Valdés P, Cuevas-Ramos D, Aguilar-Salinas CA.
    Clin Chim Acta; 2015 Jan 01; 438():160-5. PubMed ID: 25172037
    [Abstract] [Full Text] [Related]

  • 19. In vitro lipolysis of human VLDL: effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia.
    van Barlingen HH, Kock LA, de Man FH, Erkelens DW, de Bruin TW.
    Atherosclerosis; 1996 Mar 01; 121(1):75-84. PubMed ID: 8678926
    [Abstract] [Full Text] [Related]

  • 20. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.
    Hunt SC, Wu LL, Hopkins PN, Stults BM, Kuida H, Ramirez ME, Lalouel JM, Williams RR.
    Arteriosclerosis; 1989 Mar 01; 9(3):335-44. PubMed ID: 2497719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.